The Conference

 

The conference is about the key trends that will change the Immune profiling business in the coming years.

Our specific major themes include:

 

CHARACTERISATION OF THE IMMUNERESPONSE

  • The dual role of biomarkers for understanding basic principles and devising novel intervention strategies in tuberculosis
  • Analysis of the immune system during HIV infection
  • Optimized immune profiling by understanding T-cell and B-cell repertories during cancer

BIOMARKERS AND SURROGATE MARKERS OF VACCINE EFFICACY AND SAFETY

  • Signatures and ink spots of vaccine induced responses
  • Skin immunity for vaccination using omics to better describe the innate immunity and to predict the adaptive immunity
  • Systems integration of innate and adaptive immunity: Implications for vaccine development

 

IMMUNOSEQUENCING AND HIGH THROUGHPUT ANALYSIS

  • Predictive & Precision medicine: Diagnostic testing, biomarkers and immunoassay systems
  • Rapidly screening a novel affinity scaffold library for PD-L1 Inhibitors 
  • Immunosequencing: Combining high-throughput sequencing and bioinformatics to profile T-cell and B-cell receptors 
  • Single-cell technologies: Validating discoveries and translating them into clinically useful diagnostic assays 
  • Utilising next generation sequencing for fast and accurate processing of sequencing data from T- and B- cell receptor libraries 
  • Developing novel antibody immunotherapies that help the immune system attack diseased cells

IMMUNOTHERAPY AND PROFILING IN CANCER

  • Next generation of immune checkpoint inhibitors 
  • Identifying solutions to improve the efficacy of PD-1 and CTLA-4 
  • Direct identification of neo-epitopes for cancer vaccines and adoptive T-Cell therapies 
  • Next generation CAR Technology: Amplifying the immune response within the tumour microenvironment 
  • Identifying immunogenic mutations to create immune diagnostics and effective immune monitoring of patients

 

APPLY TO SPEAK

Sign Up for Event Updates